Chan Whiting
0009-0001-2040-4227
1 paper found
Refreshing results…
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Missing publications? Search for publications with a matching author name.